San Diego

(PROG) Long Term Investor Alert: Johnson Fistel Investigates Progenity; Should Management be Held Accountable for Investors Losses?

Saturday, June 19, 2021 - 8:00am

Johnson Fistel, LLP is investigating potential claims on behalf of Progenity, Inc. (NASDAQ: PROG) against certain current and former officers and directors.

Key Points: 
  • Johnson Fistel, LLP is investigating potential claims on behalf of Progenity, Inc. (NASDAQ: PROG) against certain current and former officers and directors.
  • In June 2020, Progenity completed its initial public offering (the "IPO"), in which it issued approximately 6.7 million shares for $15.00 per share.
  • Several months after the IPO, a class action lawsuit was filed in federal court against the Company.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia.

(OCGN) Ocugen Class Action Alert: Investors With Losses Over $250,000 Interested in Being a Lead Plaintiff – Contact Johnson Fistel

Saturday, June 19, 2021 - 1:28am

The class action is on behalf of shareholders who purchased Ocugen between February 2, 2021 and June 10, 2021, both dates inclusive (the "Class Period").

Key Points: 
  • The class action is on behalf of shareholders who purchased Ocugen between February 2, 2021 and June 10, 2021, both dates inclusive (the "Class Period").
  • If you wish to serve as lead plaintiff in this class action, you must move the Court no later than August 17, 2021.
  • A lead plaintiff will act on behalf of all other class members in directing theOcugen class action lawsuit.
  • If you are an Ocugen shareholder and have losses greater than $250,000, and are interested in learning more about being a lead plaintiff, please contact Jim Baker ( jimb@johnsonfistel.com ) at 619-814-4471.

Horizon Power and PXiSE Energy Solutions Successfully Operate World’s First 100% Solar-Plus-Storage-Only Community Grid

Friday, June 18, 2021 - 2:00pm

In a project that was nearly two years in the making, Horizon Power commissioned PXiSE to deploy the distributed energy resource management system (DERMS) in Onslow.

Key Points: 
  • In a project that was nearly two years in the making, Horizon Power commissioned PXiSE to deploy the distributed energy resource management system (DERMS) in Onslow.
  • Horizon Power CEO Stephanie Unwin said, Renewable energy solutions are front of mind, and we have very clear goals for our energy future.
  • This is a significant milestone for energy control technology and renewable energy, with broad applications for the world at large, said PXiSE Energy Solutions CEO Patrick Lee.
  • The project with Horizon Power in Onslow more generally will enable the town to operate a much greener grid.

Codex DNA Announces Pricing of Initial Public Offering

Friday, June 18, 2021 - 3:16am

SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Codex DNA), creators of the BioXp system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today announced the pricing of its initial public offering of 6,666,665 shares of its common stock at a public offering price of $16.00 per share.

Key Points: 
  • SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Codex DNA), creators of the BioXp system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today announced the pricing of its initial public offering of 6,666,665 shares of its common stock at a public offering price of $16.00 per share.
  • All of the shares are being offered by Codex DNA.
  • The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Codex DNA, are expected to be $106.7 million.
  • In addition, Codex DNA has granted the underwriters a 30-day option to purchase up to an additional 999,999 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

(PHG) Alert: Did You Lose Money on Your Koninklijke Philips Investment? Contact Johnson Fistel Regarding Investigation

Thursday, June 17, 2021 - 3:50pm

Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Koninklijke Philips N.V. ("Philips" or "the Company") (NYSE: PHG).

Key Points: 
  • Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Koninklijke Philips N.V. ("Philips" or "the Company") (NYSE: PHG).
  • Specifically, the Company disclosed "possible risks to users related to the sound abatement foam used in certain of Philips sleep and respiratory care devices currently in use."
  • Then on June 14, 2021, Philips Initiated a voluntary recall of some of its sleep and respiratory care devices due to health concerns.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia.

Genasys Inc. Announces Zonehaven Launch in Alameda County, CA

Thursday, June 17, 2021 - 1:45pm

This week, Alameda County and Genasys Zonehaven finalized and released 1,076 evacuations zones for the countys 1.7 million residents and initiated a "Know Your Zone" campaign.

Key Points: 
  • This week, Alameda County and Genasys Zonehaven finalized and released 1,076 evacuations zones for the countys 1.7 million residents and initiated a "Know Your Zone" campaign.
  • Under a multi-year contract, Genasys will provide planning, training, and resources to Alameda County first responders, public safety agencies, and cities to manage emergency evacuations and repopulations.
  • "Alameda Countys launch of the "Know Your Zone" campaign helps residents and businesses be better prepared for the next evacuation or emergency," said Zonehaven General Manager, Charlie Crocker.
  • The Office of Emergency Services welcomes this collaborative effort between fire, law enforcement and Zonehaven to activate "Know Your Zone" in Alameda County."

Turning Point Therapeutics Granted FDA Orphan Drug Designation for TPX-0022 in Gastric Cancer

Thursday, June 17, 2021 - 1:30pm

We are pleased to receive this designation for TPX-0022 as we work to develop it as a potentially differentiated option for patients affected by MET-driven gastric cancer.

Key Points: 
  • We are pleased to receive this designation for TPX-0022 as we work to develop it as a potentially differentiated option for patients affected by MET-driven gastric cancer.
  • There are currently no approved MET inhibitors for the treatment of gastric cancer and gastroesophageal junction adenocarcinoma.
  • Orphan Drug Designation is granted by the FDA to assist in the development of drug candidates that may offer therapeutic benefits for diseases with a prevalence of fewer than 200,000 patients annually.
  • The company is driven to develop therapies that mark a turning point for patients in their cancer treatment.

(CCIV) Deadline Alert: Investors With Losses Over $250,000 Interested in Being a Lead Plaintiff in Securities Fraud Class Action Lawsuit Against Churchill Capital Corp IV– Contact Johnson Fistel

Thursday, June 17, 2021 - 12:11pm

SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Churchill Capital Corp IV ("Churchill Capital " or the "Company") (NYSE: CCIV).

Key Points: 
  • SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Churchill Capital Corp IV ("Churchill Capital " or the "Company") (NYSE: CCIV).
  • A lead plaintiff will act on behalf of all other class members in directing theChurchill Capital class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate theChurchill Capital class-action lawsuit.
  • An investor's ability to share any potential future recovery of theChurchill Capital class action lawsuit is not dependent upon serving as lead plaintiff.

Progenity Establishes Inflammatory Bowel Disease Clinical Advisory Board

Thursday, June 17, 2021 - 12:30pm

SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the formation of its Inflammatory Bowel Disease Clinical Advisory Board.

Key Points: 
  • SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the formation of its Inflammatory Bowel Disease Clinical Advisory Board.
  • The advisory board includes respected researchers and clinicians who are thought leaders in the research and treatment of inflammatory bowel disease (IBD).
  • The advisory board will provide clinical and strategic guidance on Progenitys ingestible therapeutics and diagnostics pipeline, as the company transitions from preclinical to clinical studies.
  • This data will enable the clinical advisory board to refine Progenitys clinical development plan for its lead candidates with clinical trials expected to begin in 2022.

Hawaiian Utility Deploys EV ARC™ Solar-Powered EV Charging Systems and ARC Mobility™ Trailer

Thursday, June 17, 2021 - 1:00pm

SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Beam Global , (Nasdaq: BEEM , BEEMW), the leading provider of innovative sustainable technology for electric vehicle (EV) charging, outdoor media and energy security, announced that a utility in the State of Hawaii deployed two EV ARC solar-powered EV charging systems to charge utility fleet electric vehicles and an ARC Mobility trailer to move them around.

Key Points: 
  • SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Beam Global , (Nasdaq: BEEM , BEEMW), the leading provider of innovative sustainable technology for electric vehicle (EV) charging, outdoor media and energy security, announced that a utility in the State of Hawaii deployed two EV ARC solar-powered EV charging systems to charge utility fleet electric vehicles and an ARC Mobility trailer to move them around.
  • The EV ARC solar-powered charging systems generate and store their own electricity and can charge fleet vehicles during inclement weather, emergencies and at night.
  • The EV ARC units are off-grid and can be easily transported to different locations by the ARC Mobility trailer as charging patterns change, offices relocate or for emergencies.
  • EV ARC solar-powered EV charging systems are perfect for Island environments, reducing dependence on expensive imported carbon-heavy gas and diesel.